Disclosed is a substituted nitroimidazole derivative, which is mainly used for treating related diseases caused by mycobacterial infections, such as Mycobacterium tuberculosis, especially being suitable for diseases caused by resistant Mycobacterium tuberculosis.En la presente se revela un derivado sustituido de nitroimidazol, que se utiliza principalmente para el tratamiento de enfermedades relacionadas causadas por infecciones con mycobacterias, tales como Mycobacterium tuberculosis, siendo especialmente adecuado para las enfermedades causadas por variantes resistentes de Mycobacterium tuberculosis.